ストックスクリーナーアプリを入手
198.38
0.35%
0.70
アフターアワーズ：
198.38
前日終値:
$197.68
開ける：
$199.53
24時間の取引高:
1.14M
Relative Volume:
0.98
時価総額：
$28.12B
収益：
$2.31B
当期純損益:
$-208.16M
株価収益率:
-129.10
EPS:
-1.5366
ネットキャッシュフロー:
$76.11M
1週間 パフォーマンス:
-0.29%
1か月 パフォーマンス:
-6.09%
6か月 パフォーマンス:
+13.08%
1年 パフォーマンス:
+32.92%
1日の値動き範囲:
$197.75
$203.29
1週間の範囲:
$186.07
$203.29
52週間の値動き範囲:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
198.38 | 28.02B | 2.31B | -208.16M | 76.11M | -1.5366 |
|
TMO
Thermo Fisher Scientific Inc
|
472.71 | 174.60B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.21 | 135.34B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
586.98 | 46.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.75 | 31.60B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
296.99 | 28.45B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 開始されました | Citigroup | Buy |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-27 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 再開されました | Wells Fargo | Equal Weight |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Insider Selling: Natera (NASDAQ:NTRA) Director Sells 122 Shares of Stock - MarketBeat
Natera director Chapman sells $23348 in shares By Investing.com - Investing.com India
Natera Looks Compelling As Oncology Testing Momentum Keeps Building (NASDAQ:NTRA) - Seeking Alpha
Natera named Healthcare Technology Company of the Year - The Healthcare Technology Report.
Assessing Natera (NTRA) Valuation After New Signatera Data And Zenith Genomics Launch - simplywall.st
Holocene Advisors LP Decreases Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Boothbay Fund Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat
Natera executive chairman sells $38.3 million in NTRA stock - Investing.com
NeoGenomics, Natera, and Amphastar Pharmaceuticals Stocks Soar—Key Information You Should Be Aware Of - Bitget
NeoGenomics, Natera, and Amphastar Pharmaceuticals shares skyrocket, what you need to know - MSN
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - TradingView
Why Natera Stock Is Surging On Fresh Optimism - TipRanks
NTRA Debuts Zenith Genomics Next-Gen Sequencing Test for Rare Diseases - Yahoo Finance
Natera (NTRA) Highlights Promising Results for Signatera in Canc - GuruFocus
Natera ctDNA test shows promise in anal, rectal cancer studies - Investing.com
Natera ctDNA test shows promise in anal, rectal cancer studies By Investing.com - Investing.com India
Fred Alger Management LLC Buys 41,303 Shares of Natera, Inc. $NTRA - MarketBeat
Farallon Capital Management LLC Sells 568,357 Shares of Natera, Inc. $NTRA - MarketBeat
Cancer DNA test ties anal and rectal tumors to relapse odds - Stock Titan
Natera launches whole genome sequencing test for rare diseases - Investing.com Nigeria
Coatue Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Capital Impact Advisors LLC Boosts Stock Position in Natera, Inc. $NTRA - MarketBeat
Aquatic Capital Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat
Pinnbrook Capital Management LP Makes New $5.78 Million Investment in Natera, Inc. $NTRA - MarketBeat
Guidance Update: Can Natera Inc keep up with sector leadersPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Natera Launches Zenith Genomics To Expand Rare Disease Testing Story - simplywall.st
Zenith Genomics Launch Could Be A Game Changer For Natera’s (NTRA) Rare Disease Strategy - Yahoo Finance
Meridiem Capital Partners LP Invests $11.90 Million in Natera, Inc. $NTRA - MarketBeat
Quantitative Investment Management LLC Acquires 6,152 Shares of Natera, Inc. $NTRA - MarketBeat
16,650 Shares in Natera, Inc. $NTRA Purchased by Magnetar Financial LLC - MarketBeat
Korea Investment CORP Cuts Position in Natera, Inc. $NTRA - MarketBeat
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - Sahm
MyOme Debuts Zenithtm Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - lelezard.com
[144] Natera, Inc. SEC Filing - Stock Titan
GeneDx stock falls as Natera launches competing rare disease test - Investing.com UK
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Natera announces commercial launch of Zenith genomics - TipRanks
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis - BioSpace
Natera, Inc. $NTRA Shares Sold by Swiss National Bank - MarketBeat
Natera, Inc. $NTRA Shares Bought by Franklin Resources Inc. - MarketBeat
Capital Fund Management S.A. Buys 41,307 Shares of Natera, Inc. $NTRA - MarketBeat
Natera director Sheena Jonathan sells $25924 in stock - Investing.com Australia
Natera president Fesko sells $144k in shares By Investing.com - Investing.com Canada
Natera president Fesko sells $144k in shares - Investing.com
Natera director Sheena Jonathan sells $25924 in stock By Investing.com - Investing.com India
Natera: Daniel Rabinowitz sells $356k in shares By Investing.com - Investing.com India
Natera: Daniel Rabinowitz sells $356k in shares - Investing.com UK
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 5,623 Shares of Stock - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 707 Shares of Stock - MarketBeat
Michael Burkes Brophy Sells 785 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera CEO Steven Chapman sells $1.15 million in shares - Investing.com Nigeria
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
2.15%
大文字化:
|
ボリューム (24 時間):